Industry

Bruce Linton, chief executive officer of Canopy Growth Corp., stands for a photograph in the Mother Room at the Canopy Growth Corp. facility in Smith Falls, Ontario, Canada, on Tuesday, Dec. 19, 2017. Canadian medical marijuana is setting the stage to go global. Canopy received $200 million from Constellation Brands last year. Now, the makers of Corona are looking to give the licensed producer another $5 billion.
Industry

Corona Owners, Constellation Brands, Plan Another Massive Cannabis Investment

Constellation Brands has already poured $200 million into the Canadian cannabis industry. Now, it’s looking to invest another $5 billion.

Aug 24, 2018 - Rob Hoffman

Bruce Linton, chief executive officer of Canopy Growth Corp., stands for a photograph in the Mother Room at the Canopy Growth Corp. facility in Smith Falls, Ontario, Canada, on Tuesday, Dec. 19, 2017. Canadian medical marijuana is setting the stage to go global. The country’s emerging legal producers have a chance to seize opportunities in other countries that could make them worldwide leaders, according to Linton. (Photo by Chris Roussakis/Bloomberg via Getty Images)

Bruce Linton, chief executive officer of Canopy Growth Corp., stands for a photograph in the Mother Room at the Canopy Growth Corp. facility in Smith Falls, Ontario, Canada, on Tuesday, Dec. 19, 2017. Canadian medical marijuana is setting the stage to go global. Canopy received $200 million from Constellation Brands last year. Now, the makers of Corona are looking to give the licensed producer another $5 billion.

Bruce Linton, chief executive officer of Canopy Growth Corp., stands for a photograph in the Mother Room at the Canopy Growth Corp. facility in Smith Falls, Ontario, Canada, on Tuesday, Dec. 19, 2017. Canadian medical marijuana is setting the stage to go global. The country’s emerging legal producers have a chance to seize opportunities in other countries that could make them worldwide leaders, according to Linton. (Photo by Chris Roussakis/Bloomberg via Getty Images)

Last autumn, Constellation Brands, the makers of Corona, announced that it would invest $200 million in the Canadian cannabis giant, Canopy Growth Corp. Now, Constellation hopes to expand their share of Canopy Growth even further with a $5 billion investment that would earn them a roughly 38 percent share of the company; they currently own approximately 10 percent, which has already earned more than $700 million, according to Constellation Brands. 

This new deal, which would give Constellation Brands a majority share in one of Canada’s leading cannabis producers, will likely constitute the first cannabis investment to be reviewed after Canada’s nationwide legal cannabis legislation was given Royal Assent this past June.

According to an interview between The Growth Op and Hans Parmar, a spokesperson for Innovation, Science and Economic Development Canada, since the deal would be a foreign investment from the United States, it will have to first be assessed for its potential impact on the Canadian economy. This would be done under the Investment Canada Act.

Ottawa to review Constellation Brands blockbuster investment in Canopy Growth0 Hops Discovered in India Could Help Bring Truly Legal CBD to Market
Navdeep Bains, Canada’s minister of innovation, science and economic development, speaks after unveiling the “Innovation Wall” during the CANSEC 2017 trade show in Ottawa, Ontario, Canada, on Wednesday, May 31, 2017. The Ministry of Innovation, Science and Economic Development will assess the pending deal for its potential impact on the Canadian economy. (Photo by David Kawai/Bloomberg via Getty Images)

This federal law allows the Canadian government to reject any significant foreign investment that would not represent a “net benefit to Canada.” The Investment Canada Act currently defines “significant” foreign investments as those “originating in trade-agreement-partner countries” that exceed $1.5 billion.

If the deal moves forward, Constellation Brands will also be given warrants that would allow them to contribute another $4.5 billion investment, which would increase their share of the company to over 50 percent. This deal would also Constellation Brands the power to choose the majority of directors on Canopy Growth’s board.

According to Market Watch, once this latest investment from Constellation Brands closes, it will represent the largest legal cannabis industry investment in history. Some analysts, like Bonnie Herzog from Wells Fargo, believe the deal will give the company a major “first-mover advantage

Canada is set to officially roll out its legal cannabis law on October 17, 2018. If shareholders and regulators approve Constellation’s proposed investment in Canopy, the deal is expected to close sometime in the coming months.


Share This

Related Articles

Last fall, Constellation Brands invested $200 million in Canadian cannabis producer Canopy Growth.

President and CEO of Constellation Brands Inc., Rob Sands.

Canada’s Senate passed Bill C-45, more commonly known as the Cannabis Act. Amendments made to the Cannabis Act concern home growing, maximum THC percentages and criminal penalties. Canada is still on track to becoming the second country on the planet to legalize recreational cannabis nationwide.

Justin Trudeau waves as the senate passes the cannabis act

While Royal Assent means that Canada will officially be legalizing cannabis, many people might be wondering when will you be able to buy weed in Canada?

A pot supporter holds up a flag to celebrate The Cannabis Act Just Got Royal Assent: Weed Will Be Legal on October 17th

Comments

Stay in the loop

Exclusive deals, original content.
Delivered to you.